Trust Signals
Key Takeaways
- TRT for confirmed hypogonadism (total testosterone below roughly 300 ng/dL on two morning draws, with symptoms) is supported by multiple randomized trials, including the multi-center Testosterone Trials (Snyder et al., NEJM, 2016).
- The 2023 TRAVERSE trial (Lincoff et al., NEJM, n=5,246) found no significant increase in major adverse cardiovascular events in middle-aged men with hypogonadism treated with testosterone, resolving a longstanding safety uncertainty.
- Peptides offered at men's health clinics such as sermorelin, BPC-157, and CJC-1295 are compounded preparations, not FDA-approved drugs; human randomized controlled trial data for most of them is limited or absent.
- Cash-pay clinic membership fees for TRT typically run in the range of $150 to $350 per month nationally; the Matthews location pricing should be confirmed directly.
- A responsible TRT intake requires two separate total testosterone measurements, LH, FSH, PSA, CBC, and hematocrit at minimum; skipping these is a red flag regardless of clinic brand.
What Is Gameday Men's Health Matthews TRT and Peptide Clinic?
Gameday Men's Health Matthews is a franchise-model men's health clinic located in or near Matthews, North Carolina, offering testosterone replacement therapy, peptide protocols, and related services. Like other Gameday locations, it operates on a direct-pay membership model with a supervising medical provider. It is one of dozens of Gameday franchise sites nationally, each operating under shared brand protocols but with local physician or PA oversight. If you are evaluating it as a TRT provider, the questions to ask are the same you would ask any clinic: what labs do they require, who oversees your care, and how do they monitor for erythrocytosis and other known risks?
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of Contents
- What services does Gameday Men's Health Matthews offer?
- Evidence ledger: TRT and common peptides
- How TRT works: mechanism with real numbers
- What most clinic pages get wrong or omit
- Peptide therapy at men's health clinics: the honest picture
- Head-to-head: in-person clinic vs. telehealth TRT
- What lab work to expect and demand
- Operational guide: how to evaluate any TRT clinic
- Cost and what drives it
- FAQ
- Sources
What Services Does Gameday Men's Health Matthews Offer?
Based on the Gameday Men's Health franchise model and publicly available information, typical services at a Matthews location include:
- Testosterone replacement therapy via injectable testosterone cypionate, topical gels, or pellets
- Peptide protocols: commonly sermorelin, CJC-1295 with or without ipamorelin, and BPC-157
- Human chorionic gonadotropin (hCG) for fertility preservation alongside TRT (availability subject to ongoing FDA compounding regulations)
- Erectile dysfunction treatment (PDE5 inhibitors, trimix)
- Basic metabolic and hormone lab panels
- Weight management support
Specific offerings change with FDA compounding guidance. HCG availability, for example, was affected by the FDA's biologics classification change in 2020. Confirm current availability directly with the Matthews clinic before making any decisions based on specific peptide availability.
Evidence Ledger: TRT and Common Peptides
| Claim or Treatment | Best Evidence Type | Effect Direction | Confidence | Key Caveat |
|---|---|---|---|---|
| TRT improves sexual function in confirmed hypogonadism | Human RCT (Testosterone Trials, Snyder et al. 2016) | Positive | High | Benefit is clearer in men with total T below 300 ng/dL; modest in low-normal range |
| TRT improves bone mineral density | Human RCT (TTrials bone sub-study) | Positive | Moderate | Fracture reduction not demonstrated in trials to date |
| TRT does not increase major cardiovascular events in hypogonadal men | Human RCT (TRAVERSE trial, Lincoff et al. NEJM 2023, n=5,246) | Non-inferior to placebo | High | Applies to men with confirmed hypogonadism and moderate CV risk; not men without hypogonadism |
| TRT causes erythrocytosis (elevated hematocrit) | Human RCT and observational data | Adverse (dose-dependent) | High | Requires monitoring every 3 to 6 months; injectable T carries higher risk than topical |
| Sermorelin increases GH/IGF-1 in growth hormone deficiency | Human clinical trial data (pre-2008 FDA approval period) | Positive | Moderate | Current compounded sermorelin purity and dose equivalence to studied formulations is unverified |
| CJC-1295 increases IGF-1 in healthy adults | Small human trial (Teichman et al. 2006, n=21) | Positive | Low | Small n, no long-term safety data, no functional or clinical outcome data |
| BPC-157 promotes tissue repair | Animal and in vitro studies primarily | Positive in rodent models | Very Low | No published human RCTs; mechanism in humans unconfirmed |
| Ipamorelin stimulates GH release | Animal and small human pharmacokinetic studies | Positive for GH pulse | Low | No human outcome trials; no FDA-approved indication |
How TRT Works: Mechanism With Real Numbers
Testosterone binds androgen receptors (AR), nuclear transcription factors encoded by a gene on the X chromosome. Ligand binding causes the receptor to dimerize, translocate to the nucleus, and regulate transcription of hundreds of target genes involved in muscle protein synthesis, erythropoiesis (via EPO upregulation), bone remodeling, and libido pathways.
Injectable testosterone cypionate, the most common TRT formulation, has an approximate half-life of 7 to 8 days in clinical use (Behre et al., published pharmacokinetic data). A standard starting dose at many clinics is 100 to 200 mg intramuscularly or subcutaneously weekly, targeting a trough total testosterone in the range of 500 to 900 ng/dL. The Testosterone Trials used a gel targeting 500 to 800 ng/dL; benefits in the sexual function domain were statistically significant compared to placebo.
A critical mechanism detail most clinic marketing omits: exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis through negative feedback on GnRH pulsatility and LH/FSH release. This suppresses endogenous production and, crucially, spermatogenesis. Men who may want future fertility need this conversation before starting, not after. This is what hCG co-administration partially addresses, though its availability as a compounded drug became more complicated after 2020.
What Most Clinic Pages Get Wrong or Omit
Erythrocytosis is underdisclosed. Injectable testosterone raises hematocrit in a meaningful portion of users. Elevated hematocrit increases blood viscosity and theoretical clotting risk. Many franchise clinics mention this in paperwork but do not adequately explain that this is the one TRT adverse effect with strong mechanistic and clinical support, requiring monitoring labs every 3 to 6 months, not just once a year.
Peptide purity is not verified at the point of sale. Compounded peptides are not subject to the same FDA batch-release testing as approved drugs. A 503A compounding pharmacy is not required to publish certificates of analysis (COAs) to end consumers. There is no public registry confirming that what is in a vial labeled "BPC-157" from a compounding pharmacy matches the label claim. This does not mean compounded peptides are fake, but it does mean you cannot verify potency independently without a third-party lab test.
Peptide Therapy at Men's Health Clinics: The Honest Picture
Growth hormone secretagogues like sermorelin, CJC-1295, and ipamorelin work by stimulating pituitary GH release rather than administering GH directly. The theoretical appeal is a more physiologic GH pulse. The practical reality is that the clinical evidence base is thin. The best available human data for CJC-1295 comes from a 2006 trial by Teichman and colleagues (n=21) showing IGF-1 increases, but this trial was short, measured a surrogate marker (IGF-1, not functional outcomes), and was not a placebo-controlled RCT at scale. No trial has shown that CJC-1295 reduces fractures, improves body composition meaningfully over diet and exercise, or extends longevity in humans.
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide derived from a sequence in gastric juice protein. Rodent studies show accelerated tendon and gut healing. There are no published randomized human trials. Its use at men's health clinics is entirely off-label and based on extrapolation from animal data.
Head-to-Head: In-Person Clinic vs. Telehealth TRT
| Factor | In-Person Clinic (Gameday-style) | Telehealth TRT Provider | Winner |
|---|---|---|---|
| Injection training | On-site, hands-on | Video instruction only | In-person |
| Convenience / access | Requires travel to Matthews location | Any device, any location in NC | Telehealth |
| Cost (TRT protocol) | Roughly $150 to $350/month (franchise range) | Roughly $100 to $250/month (varies by platform) | Often telehealth |
| Lab oversight rigor | Varies by location and provider | Varies by platform; best platforms are protocol-driven | Tie (ask specifically) |
| Physician continuity | Often consistent provider at one location | May rotate providers between visits | In-person |
| Insurance billing | Typically cash-pay only | Most are cash-pay; some bill insurance | Tie to slight telehealth edge |
| Peptide availability | Typically broader menu in-person | Restricted by platform policies | In-person |
| Regulatory oversight of peptide sourcing | Depends on which 503A pharmacy they use | Depends on which 503A pharmacy they use | Tie (neither is better by default) |
What Lab Work to Expect and Demand
A responsible TRT evaluation is not optional on the lab front. The following is the minimum a legitimate clinic should order before prescribing:
- Total testosterone: two separate early morning draws (before 10 AM) on different days. One low result is not sufficient for diagnosis by Endocrine Society guidelines.
- LH and FSH: to distinguish primary (testicular) from secondary (pituitary/hypothalamic) hypogonadism. This affects treatment choices.
- SHBG: sex hormone-binding globulin, to calculate free testosterone if needed.
- Prolactin: elevated prolactin can cause secondary hypogonadism and may indicate a pituitary adenoma requiring imaging.
- PSA: prostate-specific antigen, required before TRT in men over 40 by most guidelines; TRT is relatively contraindicated in men with untreated prostate cancer.
- CBC and hematocrit: baseline before TRT, then every 3 to 6 months on treatment.
- Comprehensive metabolic panel: liver and kidney function.
If a clinic skips any of these and moves directly to prescribing, that is a clinical red flag. It is not a paperwork inconvenience; those labs exist because TRT carries real risks that these values help predict and monitor.
Operational Guide: How to Evaluate Any TRT Clinic Including Gameday Matthews
Use this checklist when you call or visit:
- Who is the prescribing provider? Is it an MD, DO, NP, or PA? If NP or PA, ask explicitly whether there is physician oversight. In North Carolina, NPs can practice independently; oversight structure varies.
- Which pharmacy compounds your peptides? Ask if they can provide the pharmacy name and whether it is a 503A or 503B facility. A 503B outsourcing facility has more federal oversight. Ask if patient-specific COAs are available.
- What is the monitoring protocol? A responsible clinic monitors hematocrit, PSA, and testosterone levels at least every 6 months on stable therapy. More frequently in the first 6 months.
- What is the cancellation and dose-adjustment policy? Legitimate clinics allow dose adjustments based on lab results without extra fees.
- How do they handle fertility goals? If you have not completed your family, ask specifically about HCG, clomiphene, or FSH preservation protocols. If the provider cannot answer this question confidently, that tells you something.
Cost and What Drives It
Gameday Men's Health locations operate on a membership model, typically bundling consultation, protocol, and medication costs. Based on franchise pricing reported publicly and in patient forums, monthly costs for basic TRT programs at Gameday locations nationally range from roughly $150 to over $300 per month. Labs may be additional. Peptide add-ons typically cost extra per protocol.
The Matthews location pricing should be confirmed directly, as franchise pricing can vary by region and competitive market. North Carolina has a moderately competitive men's health clinic market, which can exert some downward pressure on pricing relative to less competitive markets.
For comparison: retail pharmacy testosterone cypionate without insurance costs less than $50 per month for the medication itself. The clinic fee covers provider time, monitoring infrastructure, and convenience. That overhead is legitimate, but knowing the medication commodity cost helps you assess how much you are paying for service versus drug.
FAQ
What is Gameday Men's Health Matthews TRT and peptide clinic?
Gameday Men's Health Matthews is a franchise location of the Gameday Men's Health national chain specializing in testosterone replacement therapy and related men's health services including peptide protocols, located in or near Matthews, North Carolina.
What services does Gameday Men's Health Matthews offer?
Typical services include TRT via injectable testosterone cypionate, topical gels, or pellets; peptide therapy such as sermorelin, CJC-1295, and BPC-157; thyroid support; and erectile dysfunction treatment. Specific offerings change with regulations and should be confirmed directly.
How much does TRT cost at Gameday Men's Health Matthews?
Franchise men's health clinics typically charge monthly membership fees in the range of $150 to $350 for TRT. Exact Matthews pricing should be confirmed directly, as it may differ from national averages and can change.
Is TRT evidence-based?
TRT for men with clinically confirmed hypogonadism (total testosterone below roughly 300 ng/dL on two morning samples, with symptoms) is supported by multiple randomized trials including the Testosterone Trials. TRT for men in the low-normal range has less certain benefit-risk ratios.
Are peptides offered at Gameday Men's Health Matthews FDA-approved?
No. Peptides such as sermorelin, BPC-157, and CJC-1295 as offered at men's health clinics are compounded preparations, not FDA-approved drugs for these indications. This means less regulatory oversight on purity and potency compared to approved medications.
What lab work should I expect before starting TRT?
A legitimate TRT evaluation should include at minimum: two early morning total testosterone measurements on separate days, LH, FSH, SHBG, prolactin, CBC, comprehensive metabolic panel, PSA (age-appropriate), and hematocrit. Reputable clinics also check estradiol and thyroid function.
What are the real risks of TRT I should know before visiting?
The main documented risks include erythrocytosis (elevated red blood cell count raising clot risk), suppression of endogenous testosterone and spermatogenesis, potential worsening of sleep apnea, and uncertain long-term cardiovascular effects. The TRAVERSE trial (2023) found no significant increase in major adverse cardiovascular events in men with hypogonadism, but this applies to that specific population.
How do I evaluate whether a TRT clinic is operating responsibly?
Key indicators: pre-treatment labs including two testosterone measurements, licensed physician oversight, ongoing hematocrit monitoring every 3 to 6 months, transparent pricing without aggressive upselling, and willingness to discuss fertility preservation options such as hCG or clomiphene.
What is the difference between TRT and peptide therapy?
TRT directly replaces testosterone, a hormone with decades of clinical trial data. Peptide therapy uses short amino acid chains to signal the body to produce hormones or promote tissue repair. Peptides have far less clinical trial evidence; most human data is limited and most mechanistic data comes from animal or in vitro studies.
Can I get TRT online instead of visiting a Matthews clinic?
Yes. Telehealth TRT providers operate legally in North Carolina and require the same labs with comparable protocols. In-person clinics add the benefit of on-site injection training and direct provider relationships, which some patients prefer.
Does insurance cover TRT at Gameday Men's Health Matthews?
Gameday Men's Health locations typically operate on a cash-pay membership model and do not bill insurance directly. Patients may submit claims independently, but coverage depends heavily on the plan and diagnosis code. Confirm directly with the Matthews clinic.
Sources
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of Testosterone Treatment in Older Men. New England Journal of Medicine. 2016;374(7):611-624.
- Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. New England Journal of Medicine. 2023;389(2):107-117. (TRAVERSE trial)
- Teichman SL, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology and Metabolism. 2006;91(3):799-805.
- Endocrine Society Clinical Practice Guideline: Testosterone Therapy in Men with Hypogonadism. Journal of Clinical Endocrinology and Metabolism. 2018;103(5):1715-1744.
- FDA. Compounding and the FDA: Questions and Answers. FDA.gov. Accessed 2026.
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline. JCEM. 2018.
- Behre HM, Nieschlag E. Testosterone preparations for clinical use in males. In: Nieschlag E, Behre HM, eds. Testosterone: Action, Deficiency, Substitution. 4th ed. Cambridge University Press; 2012.
- Sikirić PC, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Pharmaceutical Design. 2011;17(16):1612-1632.
Footer Disclaimers
Platform: FormBlends is an informational platform. Content on this page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. Consult a licensed healthcare provider before starting any hormone or peptide protocol.
Research Compound and Compounded Medication Notice: Peptides discussed on this page are either research-use compounds or compounded medications not approved by the FDA for the indications described. Their safety and efficacy profiles in humans are less established than approved pharmaceuticals.
Results Disclaimer: Individual results from TRT or peptide therapy vary substantially based on baseline hormone levels, age, lifestyle factors, adherence, and other variables. Published trial averages do not predict individual outcomes.
Trademark Notice: "Gameday Men's Health" is a registered trademark of its respective owner. FormBlends is not affiliated with, endorsed by, or sponsored by Gameday Men's Health or any of its franchise locations. References to the brand are purely informational.